Harvard Bioscience Stock News

Harvard Bioscience (HBIO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thr

The logic behind this strategy for stock selection is to identify stocks that are trading within a narrow band.

Value investors look for inexpensive stocks that have growth potential. They often see low cost stocks as being on sale or undervalued.

This is probably the time to focus on fundamentals because we don't want to overpay for stocks in a buoyant market.

Harvard Bioscience (HBIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2021 Results - Earnings Call Transcript

Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins

HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6

Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q4 2020 Results - Earnings Call Transcript

HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on Ma

HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (“Harvard Bioscience”) today announced the refinancing of its debt with the closing of a new $65 million

HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The

Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q3 2020 Results - Earnings Call Transcript

Moderator Kristen Welker, with the help of an offstage mute button, helped give Americans a substantive head-to-head debate over leadership that had been missing during the presidential campaign

Your investment manager may be signing a pledge to urge companies you own to address any human rights problems, anticipate them, and remedy them.